Additionally, it has been investigated for potential relevance to conditions like skin inflammation, chronic obstructive pulmonary disease, and metastatic colon cancer, owing to its ability to regulate thousands of human genes, with observed effects on resetting DNA expression patterns
Reduces Cardiovascular Risk Beyond weight loss, the SELECT trial proved Semaglutide reduces the risk of heart attack, stroke, and cardiovascular death in overweight or obese individuals
Timothy Wood from the Colorado Childrens Hospital
Some people find this helps manage side effects while maintaining appetite suppression
Conagra Brands added a GLP-1 Friendly label to 26 of its Healthy Choice frozen meals in early 2025
Love the packaging, easy to use and understand, good formula